semaglutide discontinuation study denmark 2025 september evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of in early-stage symptomatic Alzheimer's disease | Alzheimer's Research & Therapy Research finds half of Ozempic

The Authority stressed that it has not approved any oral GLP-1 solution for consumption

Without healthy mitochondria, all cells, particularly those of the nervous system, would not function properly leading to cell damage and eventual cell death.

pH and excipient effects A formulation optimized for pharmaceutical tesamorelin may not be optimized for ipamorelin, and vice versa

And I think you know, we had talked about it in another episode, how if someone just stops an antipsychotic, the relapse rate is 95%

Negut I, Grumezescu V, Grumezescu AM

Similar dynamics are evident across other appetite-regulating peptide systems that warrant renewed evaluation under modern translational paradigms